Introduction: The 1985 Hames Consortium convened family medicine researchers to identify outstanding questions in their practice.
Method: In this descriptive review, we collected, codified, and analyzed available literature to describe the availability of evidence to answer these questions.
Results: Of 136 total questions, researchers rated 33 questions as not at all answered (24.
Objectives: To evaluate the tolerability of crovalimab versus eculizumab in C5 inhibitor (C5i)-naive and -experienced patients with PNH from COMMODORE 2, 3 and 1 (NCT04434092, NCT04654468 and NCT04432584).
Methods: Pooled safety data were assessed in the total crovalimab and eculizumab populations and by C5i-naive versus C5i-switched status in patients receiving crovalimab. Analyses include 6.
Background: While enteric viruses are highly transmissible, household factors associated with transmission are less well documented. We identified individual- and household-level factors associated with viral acute gastroenteritis (AGE) transmission in a large health care network in the United States.
Methods: Patients presenting with AGE were enrolled from April 2014 to September 2016.